Evidence map›Paper›PMID 30104808›Full record

ArticleColombia medica (Cali, Colombia)2018

A study of community-acquired

Hong-Xia Yu, Mao-Mao Zhao, Zeng-Hui Pu, Yuan-Rong Ju, Yan Liu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Colombia medica (Cali, Colombia), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hong-Xia YuPneumology Department, Shandong Provincial Hospital. Shandong University, Jinan, China.
Mao-Mao ZhaoDepartment of Infectious Diseases, Yantai Yuhuangding Hospital. Qingdao University, Yantai, China.
Zeng-Hui PuDepartment of Infectious Diseases, Yantai Yuhuangding Hospital. Qingdao University, Yantai, China.
Yuan-Rong JuPneumology Department, Shandong Provincial Hospital. Shandong University, Jinan, China.
Yan LiuDepartment of Infectious Diseases, Yantai Yuhuangding Hospital. Qingdao University, Yantai, China.
Shandong Provincial Hospital · CNYuhuangding Hospital · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCommunity-acquired pneumonia (CAP) is a global disease responsible for a large number of deaths, with significant economic impact. As diagnostic tools have increased in sensitivity, understanding of the etiology of CAP has begun to change.

objectiveTo investigate the rate and mechanism of macrolide resistance in Yantai.

methodsPharyngeal swab samples were collected from adult CAP patients. Samples were assayed by polymerase chain reaction (PCR) and cultivated to test for

resultsOut of 128 samples tested, 27 were positive for

conclusionsMacrolides are not the first-line treatment for

Indexed as

AdolescentAdultAgedAnti-Bacterial AgentsChinaCommunity-Acquired InfectionsDrug Resistance, BacterialFemaleHumansMacrolidesMaleMiddle AgedMycoplasma pneumoniaePneumonia, MycoplasmaPoint MutationPolymerase Chain ReactionAnti-Bacterial AgentsMacrolidesadultcommunity-acquired pneumoniadrug resistanceMycoplasma pneumoniaetherapy

Identifiers

PMID30104808
PMCPMC6084921
OpenAlexW2890489265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.